<SEC-DOCUMENT>0001185185-24-000360.txt : 20240405
<SEC-HEADER>0001185185-24-000360.hdr.sgml : 20240405
<ACCEPTANCE-DATETIME>20240405113315
ACCESSION NUMBER:		0001185185-24-000360
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240320
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240405
DATE AS OF CHANGE:		20240405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IGC Pharma, Inc.
		CENTRAL INDEX KEY:			0001326205
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202760393
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32830
		FILM NUMBER:		24825440

	BUSINESS ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854
		BUSINESS PHONE:		301-983-0998

	MAIL ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	India Globalization Capital, Inc.
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>igcpharma20240320_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 05 15:25:16 UTC 2024 -->
<html xmlns:igc="http://www.igcinc.us/20240320" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
	<title>igcpharma20240320_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 4/5/2024 3:20:30 PM -->

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div>
</div><hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/><div>
</div><hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/><div>
</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></p><div>

</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b>&#160;&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p><div>

</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-374">8-K</ix:nonNumeric></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-47"><b><span style="text-decoration:underline">March 20, 2024</span></b></ix:nonNumeric></p><div>

</div><div style="text-align: center;"><img alt="igc_logo1.jpg" src="igc_logo1.jpg"/></div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">	<p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-61"><b><span style="text-decoration:underline">IGC PHARMA, INC.</span></b></ix:nonNumeric></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Exact name of registrant as specified in charter)</p>	</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">&#160;</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 2pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-73"><b><span style="text-decoration:underline">Maryland</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:8.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-78"><b><span style="text-decoration:underline">001-32830</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:6.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 13pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-83"><b><span style="text-decoration:underline">20-2760393</span></b></ix:nonNumeric></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 3pt;">(State or other jurisdiction of incorporation)</p>	</td>	<td style="vertical-align:top;width:8.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Commission File Number)</p>	</td>	<td style="vertical-align:top;width:6.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 13pt;">(I.R.S. Employer Identification No.)</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">&#160;</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-375">10024 Falls Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-376">Potomac</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-377">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-378">20859</ix:nonNumeric></span></b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;">(Address of principal executive offices) (Zip Code)</p>	</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">&#160;</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	<td style="vertical-align:top;width:8.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><b><span style="text-decoration:underline">(<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-379">301</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-380">983-0998</ix:nonNumeric></span></b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Registrant&#8217;s telephone number, including area code)</p>	</td>	<td style="vertical-align:top;width:6.4%;">&#160;</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed since Last Report)</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:middle;width:0.5%;">&#160;</td>	<td style="vertical-align:top;width:1.5%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:WrittenCommunications" id="ixv-381">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:0.5%;">&#160;</td>	<td style="vertical-align:top;width:1.5%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:SolicitingMaterial" id="ixv-382">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:0.5%;">&#160;</td>	<td style="vertical-align:top;width:1.5%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementTenderOffer" id="ixv-383">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:0.5%;">&#160;</td>	<td style="vertical-align:top;width:1.5%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementIssuerTenderOffer" id="ixv-384">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>	</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align: top; width: 8.6%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></p>	</td>	<td style="vertical-align: top; width: 4.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol(s)</b></p>	</td>	<td style="vertical-align: top; width: 8.6%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></p>	</td>	</tr>	<tr>	<td style="vertical-align: top; width: 8.6%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle" id="ixv-385">Common Stock, $.0001 par value</ix:nonNumeric></p>	</td>	<td style="vertical-align: top; width: 4.3%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol" id="ixv-386">IGC</ix:nonNumeric></p>	</td>	<td style="vertical-align: top; width: 8.6%; border: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-387">NYSE American</ix:nonNumeric></p>	</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (&#167;240.12b-2 of this chapter)</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="ixv-388">&#9744;</ix:nonNumeric>.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:8.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#160;7<b>.01</b></p>
			</td>
			<td style="vertical-align:top;width:94.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Regulation FD Disclosure</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">On Wednesday, March 20, 2024, IGC Pharma Inc. (&#8220;IGC&#8221; or the &#8220;Company&#8221;) issued a press release announcing positive interim results for IGC-AD1 in reducing Alzheimer&#8217;s agitation. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>The information furnished under Item 7.01 and Item 9.01 of this Current Report on Form 8-K, including the exhibit, shall not be deemed </i>&#8220;<i>filed</i>&#8221;<i> for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference in any registration statement or other filings of the Company under the Securities Act of 1933, as amended, except as shall be set forth by specific reference in such filing.</i></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:8.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#160;<b>8.01</b></p>
			</td>
			<td style="vertical-align:top;width:94.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Other Events.</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On March 20, 2024, the Company issued a press release announcing the results of an interim analysis of its ongoing Phase 2 trial investigating IGC-AD1 as a treatment for Agitation in dementia from Alzheimer&#8217;s Disease (&#8220;AAD&#8221;).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer&#8217;s disease, indicating strong therapeutic potential for IGC-AD1.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The study's primary goal is to assess the change in AAD after six weeks using a standard scale, the Cohen Mansfield Agitation Inventory (&#8220;CMAI&#8221;). Based on interim data, patients taking IGC-AD1, on average, experienced a more significant reduction in agitation scores compared to those on placebo, and the positive effects were observed as early as week two of the trial.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At the primary outcome, assessing the change in agitation as measured by the CMAI at week 6, the Cohen&#8217;s d effect size indicating the superiority of IGC-ADI over placebo was 0.66. The CMAI Least Square (&#8220;LS&#8221;) mean difference between active, and placebo was -10.45, with a p-value of 0.037 (for combined week two and week six results). In addition, at the pre-specified secondary endpoint, change at week two, the effect size was 0.79. The Cohen&#8217;s d is a standardized statistical effect size that describes the magnitude of the difference between two groups, taking into account the variability in outcomes.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:8.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01</b></p>
			</td>
			<td style="vertical-align:top;width:94.6%;"><b>Financial Statements and Exhibits</b></td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 189px;"><b><span style="text-decoration:underline">Exhibit No</span></b>.</td>
			<td style="vertical-align: top; width: 1566px;"><b><span style="text-decoration:underline">Description</span></b></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 189px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">99.1&#160;</p>
			</td>
			<td style="vertical-align: top; width: 1566px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_642530.htm" style="-sec-extract:exhibit;">Press Release dated March 20, 2024.</a></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 189px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</p>
			</td>
			<td style="vertical-align: top; width: 1566px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About IGC Pharma Inc. (IGC):</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Pharma Inc. (&#8220;IGC&#8221;) is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. The Company's mission is to transform the landscape of Alzheimer's treatment with a robust pipeline of five promising drug candidates. IGC-AD1 and LMP target the hallmarks of Alzheimer's disease, including neuroinflammation, A&#946; plaques, and neurofibrillary tangles. IGC-AD1 is currently undergoing a Phase 2 clinical trial for agitation in dementia associated with Alzheimer's (<span style="text-decoration:underline">clinicaltrials.gov</span>, CT05543681). TGR-63 disrupts the progression of Alzheimer's by targeting A&#946; plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of A&#946; plaques, potentially impacting early-stage Alzheimer's. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer's therapy. In addition to its drug development pipeline, IGC Pharma seeks to leverage Artificial Intelligence (&#8220;AI&#8221;) for Alzheimer's research. Their AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer's.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Forward-Looking Statements:</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">This 8-K contains forward-looking statements. These forward-looking statements are based largely on IGC Pharma&#8217;s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma&#8217;s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company&#8217;s failure or inability to commercialize one or more of the Company&#8217;s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA&#8217;s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma&#8217;s U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) filings. IGC Pharma incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 7, 2023, and Quarterly Report on Form 10-Q filed with the SEC on February 14, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:8.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC Pharma, Inc.</b></p>
			</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.6%;">&#160;</td>
			<td style="vertical-align:top;width:7.5%;">&#160;</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.6%;">&#160;</td>
			<td style="vertical-align:bottom;width:7.5%;">&#160;</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: April 5, 2024</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#160;Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.6%;">&#160;</td>
			<td style="vertical-align:top;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name: Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.6%;">&#160;</td>
			<td style="vertical-align:top;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: CEO</p>
			</td>
			<td style="vertical-align:top;width:2.6%;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-391">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-392">0001326205</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="igc-20240320.xsd" xlink:type="simple"/></ix:references>
<ix:resources><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEJJbsMOu/Fc4zrxZ6p1ODLYx8Mi4nTfC/W/aZKc55hSybPN5tERcZnYaSn56cK/kPJZYuUj+ZrXVLeju2CBFZL1BAVmOG4TTUh3Lg4MF1SSlhTp4CV+3iU1wdHTKCs5TWQ==] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-03-20</xbrli:startDate>
    <xbrli:endDate>2024-03-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_642530.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_642530.htm</title>
	<!-- Generated by ThunderDome Portal - 4/5/2024 3:30:37 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div><img alt="igc_logo2.jpg" src="igc_logo2.jpg"></div>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma Announces Positive Interim Results for IGC-AD1 in </b></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reducing Alzheimer</b>&#8217;<b>s Agitation</b></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><i>- Interim Data: Study Achieves Primary End Point Demonstrating Clinical and Statistically Significant Reductions Compared to Placebo in Agitation Associated with Dementia Due to Alzheimer</i>&#8217;<i>s Disease -</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Potomac, MD, March 20, 2024 &#8211; IGC Pharma, Inc. (&#8220;IGC Pharma&#8221;, &#8220;IGC&#8221;, or the &#8220;Company&#8221;) (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 trial investigating IGC-AD1 as a treatment for Agitation in dementia from Alzheimer&#8217;s Disease (&#8220;AAD&#8221;).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer&#8217;s disease, indicating strong therapeutic potential for IGC-AD1.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The study's primary goal is to assess the change in AAD after six weeks using a standard scale, the Cohen Mansfield Agitation Inventory (&#8220;CMAI&#8221;). Based on interim data, patients taking IGC-AD1, on average, experienced a more significant reduction in agitation scores compared to those on placebo, and the positive effects were observed as early as week two of the trial.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At the primary outcome, assessing the change in agitation as measured by the CMAI at week 6, the Cohen&#8217;s d effect size indicating the superiority of IGC-ADI over placebo was 0.66. The CMAI Least Square (&#8220;LS&#8221;) mean difference between active, and placebo was -10.45, with a p-value of 0.037 (for combined week two and week six results). In addition, at the pre-specified secondary endpoint, change at week two, the effect size was 0.79. The Cohen&#8217;s d is a standardized statistical effect size that describes the magnitude of the difference between two groups, taking into account the variability in outcomes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Pre-Specified Interim Results:</u></b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The IGC-AD1 Phase 2 is an ongoing multi-site, randomized, double-blind, placebo-controlled clinical trial that continues to enroll. IGC-AD1 is an oral liquid formulation administered twice daily for six weeks with no placebo run-in and titration to full dose over two days. Agitation is rated at the trial site, at baseline, week 2, and week 6, by a trained practitioner using the CMAI, a scale designed to measure AAD.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">"We are excited with the positive interim results from the Phase 2 trial of IGC-AD1 for agitation in dementia due to Alzheimer's disease. IGC-AD1&#8217;s interim results demonstrate a clinical and statistically significant reduction in agitation compared to placebo, suggesting a strong plausibility to address a substantial unmet medical need. This interim data validates IGC-AD1's potential as a transformative therapeutic option with a large market opportunity in Alzheimer's disease management. We are actively pursuing next steps, including with regulators, and remain committed to advancing IGC-AD1 toward commercialization. We foresee a medication that can help alleviate caregiver burden and family distress as managing Alzheimer&#8217;s patients, especially ones with agitation, can have a significant emotional toll on families. With IGC-AD1's promising clinical profile, we are confident in its ability, subject to further trials, to improve patient outcomes and drive shareholder value,&#8221; said Ram Mukunda, CEO of IGC Pharma.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>IGC-AD1 interim Statistics </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Table 1 sets out the difference in LS mean from the baseline CMAI score for the active and the placebo groups at week six. The LS mean CMAI score difference between the active and placebo groups at week six is -10.45. At weeks 2 and 6, the interim Cohen's d effect size is 0.79 and 0.66, respectively, with a p-value of 0.037 for weeks 2 and 6 combined. This interim data suggests clinical and statistically significant improvement in AAD for the group receiving IGC-AD1 compared to placebo.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Comparison with Existing Treatment</u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><br>
In May 2023, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved Brexpiprazole, an atypical antipsychotic, with a boxed warning. This approval followed a significantly larger 12- week Phase 3 trial, which showed a difference in LS mean from baseline CMAI between active and placebo of -5.32, a Cohen's d effect size of 0.35, and a p-value of 0.003 (Lee et al., 2023). The findings from several Brexpiprazole trials are summarized in Table 1 below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table 1. Results of IGC-AD1 Interim Analysis and Illustrative Brexpiprazole Phase 3 Results</b><b><sup style="vertical-align:top;line-height:120%;">1</sup></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-image: initial; font-size: 9pt;">&nbsp;</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(204, 238, 255); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>IGC AD1</b></p>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 59.9%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(230, 230, 230); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Brexpiprazole Phase 3</b></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-image: initial; font-size: 9pt;">&nbsp;</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(204, 238, 255); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Phase 2 Interim results</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(230, 230, 230); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Phase 3</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Two fixed doses</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Lee et al. 2023)</b></p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(230, 230, 230); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Phase 3</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>fixed dose</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Grossberg et al. 2020)</b></p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; background-color: rgb(230, 230, 230); font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Phase 3</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Post Hoc (subgroup)</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Grossberg et al. 2020)</b></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Trial Duration</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>6-weeks</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">12-weeks</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">12-weeks</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">12-weeks</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">ClinicalTrials.gov ID</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NCT05543681</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">NCT03548584</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">NCT01862640</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">NCT01922258</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Dosing</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>1 ml (bid)</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">2mg/3mg (qd)</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">2mg (qd)</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">2mg (qd)</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">End Of Treatment (EOT)</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Week 6</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Week 12</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Week 12</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Week 12</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Primary Outcome</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Baseline to Week </b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>6</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Baseline to Week 12</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Baseline to Week 12</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Baseline to Week 12</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Statistical Model</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>MMRM</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">MMRM</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">MMRM</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">MMRM</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Agitation Scale</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CMAI</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">CMAI</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">CMAI</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">CMAI</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">Treatment Difference in LS Mean from Baseline CMAI between Active and Placebo at EOT (95% CI)</p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>-10.46</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(-20.20, -0.72)</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">-5.32</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">(-8.77, -1.87)</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">-3.77</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;(-7.38, -0.17)</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">-5.06</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">(-8.99, -1.13)</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Cohen</b>&#8217;<b>s d Effect Size </b></p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>0.66</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.35</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.25</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.41</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: middle; width: 23.3%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>p-value </b></p>
			</td>
			<td style="vertical-align: middle; width: 17.5%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>0.037</b></p>
			</td>
			<td style="vertical-align: middle; width: 15.8%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.003</p>
			</td>
			<td style="vertical-align: middle; width: 21.9%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.040</p>
			</td>
			<td style="vertical-align: middle; width: 22.2%; border: 1px solid black; font-size: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;">0.012</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The comparison is for illustrative purposes and is not intended to provide a direct comparison of effectiveness between IGC-AD1 and Brexpiprazole.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>IGC-AD1 as a Treatment for Agitation in Alzheimer</u></b><u>&#8217;</u><b><u>s Disease </u></b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In 2023, the number of Americans living with Alzheimer&#8217;s was estimated at 6.7 million. According to one estimate, as many as 76% of them suffer from AAD (Van der Mussele et al., 2015), which is associated with an accelerated cognitive decline, increased caregiver burden, increased hospitalization, and increased need for medication, all significantly diminishing the quality of life for patients. Current therapies carry black box warnings, indicative of serious adverse reactions that may lead to death or serious injury. IGC-AD1 is designed to target AAD&#8217;s underlying causes and address the unmet need for a safe and effective therapy.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Neuroinflammation, neurotransmitter imbalance, and CB1 receptor dysfunctions are all associated with agitation in Alzheimer&#8217;s disease (Yasuno et al., 2023; Manuel et al., 2014). In addition, upregulation of inflammasome-3 has been shown to lead to neuroinflammation, consequently leading to aggressive behavior (Yu et al., 2023). IGC-AD1&#8217;s formulation combines a CB1 receptor partial agonist with anti-neuroinflammatory properties that help balance neurotransmitter imbalance and an inflammasome inhibitor that targets the upregulation of inflammasome-3.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The 146-pateint IGC-AD1 trial, for which these interim results are presented, continues to enroll in the U.S. and Canada. As the interim results are based on a small number of patients (n=26), there is no guarantee that the positive interim results will hold up as more patients are enrolled in the trial. Learn more and find information about recruitment centers at <u>https://clinicaltrials.gov/study/NCT05543681</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About IGC Pharma Inc. (IGC):</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Pharma Inc. (&#8220;IGC&#8221;) is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. The Company's mission is to transform the landscape of Alzheimer's treatment with a robust pipeline of five promising drug candidates. IGC-AD1 and LMP target the hallmarks of Alzheimer's disease, including neuroinflammation, A&#946; plaques, and neurofibrillary tangles. IGC-AD1 is currently undergoing a Phase 2 clinical trial for agitation in dementia associated with Alzheimer's (<u>clinicaltrials.gov</u>, CT05543681). TGR-63 disrupts the progression of Alzheimer's by targeting A&#946; plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of A&#946; plaques, potentially impacting early-stage Alzheimer's. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer's therapy. In addition to its drug development pipeline, IGC Pharma seeks to leverage Artificial Intelligence (&#8220;AI&#8221;) for Alzheimer's research. Their AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer's.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Forward-Looking Statements:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">This press release contains forward-looking statements. These forward-looking statements are based largely on IGC Pharma&#8217;s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma&#8217;s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company&#8217;s failure or inability to commercialize one or more of the Company&#8217;s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA&#8217;s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma&#8217;s U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) filings. IGC Pharma incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 7, 2023, and Quarterly Report on Form 10-Q filed with the SEC on February 14, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Contact:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investors</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IMS Investor Relations</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rosalyn Christian</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>igc@imsinvestorrelations.com</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(203) 972-9200</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Media</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">JVPRNY</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Janet Vasquez</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>jvasquez@jvprny.com</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(212) 645-5498</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>igc-20240320.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 05 15:25:16 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2024" targetNamespace="http://www.igcinc.us/20240320" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:igc="http://www.igcinc.us/20240320" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240320_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240320_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240320_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEJJbsMOu/Fc4zrxZ6p1ODLYx8Mi4nTfC/W/aZKc55hSybPN5tERcZnYaSn56cK/kPJZYuUj+ZrXVLeju2CBFZL1BAVmOG4TTUiFN0N2m/vt8xXaEqPjRG2mmGa/NBDEzJQ==] CSR-->
      <link:roleType roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>igc-20240320_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 05 15:25:16 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="igc-20240320.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEJJbsMOu/Fc4zrxZ6p1ODLYx8Mi4nTfC/W/aZKc55hSybPN5tERcZnYaSn56cK/kPJZYuUj+ZrXVLeju2CBFZL1BAVmOG4TTUtqs2XAH++uabq4wF68gCRcoOERM93WFfw==] CSR-->
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>igc-20240320_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 05 15:25:16 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEJJbsMOu/Fc4zrxZ6p1ODLYx8Mi4nTfC/W/aZKc55hSybPN5tERcZnYaSn56cK/kPJZYuUj+ZrXVLeju2CBFZL1BAVmOG4TTUozDI+Nk07vngeRKUX1/44JQqwQTs5pnVA==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl0" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl0" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>igc-20240320_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 05 15:25:16 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="igc-20240320.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="igc-20240320.xsd#igc_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEJJbsMOu/Fc4zrxZ6p1ODLYx8Mi4nTfC/W/aZKc55hSybPN5tERcZnYaSn56cK/kPJZYuUj+ZrXVLeju2CBFZL1BAVmOG4TTUnPxurBP0FE/ek0UBaN5N4NVtDl26vgVmw==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>igc_logo1.jpg
<TEXT>
begin 644 igc_logo1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !* &L# 2(  A$! Q$!_\0
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2;5QLQ)6+'6BBBN,H**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>igc_logo2.jpg
<TEXT>
begin 644 igc_logo2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !3 (X# 2(  A$! Q$!_\0
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M^Z4&UU*)]_E@] 3W7Z\BOHJ*1)HUDC8.C#<K*<@@]Q7R7]L9IA'[-U7\[/\
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4@"/D7_OD444HU)QDY*3N]_,#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140404758404144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IGC PHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IGC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2760393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10024 Falls Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Potomac<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983-0998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  J7(58S\@RH40$  "4$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V887/B-A"&_XK&[73:F03;,B&0 C.$)'?,'3D&<KUIOPE;@":VY4IR2/Y]
M5S;8-.>L^9!@&^WKQ[ORNQ+#O53/>L>Y(:])G.J1LS,FNW%='>YXPG1'9CR%
M;S92)<S J=JZ.E.<1450$KO4\WINPD3JC(?%M84:#V5N8I'RA2(Z3Q*FWFYY
M+/<CQW>.%Y9BNS/V@CL>9FS+5]Q\SQ8*SMQ*)1()3[60*5%\,W(F_LTM[=J
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  J7(58EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ *ER%6 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  J7(58
M&,TZKN\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  J7(58F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "I<A5C/R#*A1 0
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M2P$"% ,4    "  J7(58)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  J7(5899!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="igcpharma20240320_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.igcinc.us/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>igc-20240320.xsd</File>
    <File>igc-20240320_def.xml</File>
    <File>igc-20240320_lab.xml</File>
    <File>igc-20240320_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="igcpharma20240320_8k.htm">igcpharma20240320_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>igc_logo1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "igcpharma20240320_8k.htm": {
   "nsprefix": "igc",
   "nsuri": "http://www.igcinc.us/20240320",
   "dts": {
    "schema": {
     "local": [
      "igc-20240320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "igc-20240320_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "igc-20240320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "igc-20240320_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "igcpharma20240320_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.igcinc.us/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "igcpharma20240320_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "igcpharma20240320_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "igc_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.igcinc.us/20240320",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001185185-24-000360-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001185185-24-000360-xbrl.zip
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MXDL&XBZT\/U%X>5AE.!/)?1K4)=83Z0P0)A @))WNE!MOMYJ-M8W:L[9<)8
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MOXD5?&5R%+I]\':!X"@6V2X*W4-18QW@EA ?'19NM=BH%\-/S3ANT?*;]9D
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M5Q\,*=M?#'EF7*^_3A0 _@-02P,$%     @ *ER%6/@$\LC>!P  3T\  !0
M  !I9V,M,C R-# S,C!?;&%B+GAM;-U<6W/:.A!^/[]"A_/23DIL2$A*)DF'
M0BX$DI  :4*GTS%&@!,C4]G<\NN/9##%MF0[0.6X3Z6P6NWN]UE:>5<Y_C(=
MZ& ,L:D9Z"25V953 "+5Z&BH=Y)JUM.%>K%<3GTY!>"?XW_3:7 !$<2*!3N@
M/0-%8S"LJQIH8 6970,/P =K\!&D0=^RAD>2-)E,=E4B8ZH:AJ8QPBHTZ1<@
MG28*'95%#*G"(W".-5 88B#G0"9WE,T=90Y LU$$63F[/Q_RS[&NH9>V8D)
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MN60P)^U@$O8<3OJ"^G(8B G9C"9;Q"+C* J;Q>+5U57!@3[2X8+)(!8.D_B
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M-#(U,S N:'1M4$L! A0#%     @ *ER%6 )KN!U/!   T@P  !
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M2P$"% ,4    "  J7(58SR]!O.L)  !Q"@  #0              @ $9+P
M:6=C7VQO9V\Q+FIP9U!+ 0(4 Q0    ( "I<A5@# HV-^1<  *A_   8
M          "  2\Y  !I9V-P:&%R;6$R,#(T,#,R,%\X:RYH=&U02P4&
/  < !P#  0  7E$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>igcpharma20240320_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="igc-20240320.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2024-03-20</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0" id="ixv-374">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-47">2024-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-61">IGC PHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-73">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c0" id="ixv-78">001-32830</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-83">20-2760393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-375">10024 Falls Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-376">Potomac</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-377">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-378">20859</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-379">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-380">983-0998</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c0" id="ixv-381">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c0" id="ixv-382">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c0" id="ixv-383">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c0" id="ixv-384">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c0" id="ixv-385">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-386">IGC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-387">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-388">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0" id="ixv-391">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-392">0001326205</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
